Ironwood Pharmaceuticals | IRWD - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Acadia Pharmaceuticals USD 26.32M 18.28M 2025-12
Agios Pharmaceuticals USD -109.06M 5.62M 2025-12
Akebia Therapeutics USD -11.24M 12.39M 2025-12
Almirall EUR 30.32M 22M 2025-12
Alnylam Pharmaceuticals USD 161.14M 77.83M 2025-12
Amarin USD -852K 7.26M 2025-12
Ardelyx USD -400K 467K 2025-12
Astellas Pharma JPY 133.96B 29.77B 2025-12
AstraZeneca USD 3.24B 117M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Coherus Biosciences USD -46.35M 90.86M 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Halozyme Therapeutics USD 218.96M 14.02M 2025-09
Incyte USD 389.94M 92.37M 2025-12
Ironwood Pharmaceuticals USD 68.02M 30.2M 2025-09
Karyopharm Therapeutics USD -39.9M 9.01M 2025-12
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
MacroGenics USD -14.93M 31.75M 2025-12
Moderna USD -187M 631M 2025-09
Myriad Genetics USD 4.6M 3.4M 2025-12
Pacira USD 9.52M 11.45M 2025-09
PTC Therapeutics USD -139.08M 116.01M 2025-12
Puma Biotechnology USD 20.61M 24.76M 2024-09
Sarepta Therapeutics USD -407.67M 213.63M 2025-12
Takeda JPY 133.86B 105.69B 2025-12
Ultragenyx Pharmaceutical USD -128M 51.54M 2025-12
Vanda Pharmaceuticals USD -22.92M 16.68M 2024-12